证券代码：600252 证券简称：中恒集团 公告编号：临 2025-75 广西梧州中恒集团股份有限公司 第十届董事会第三十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 广西梧州中恒集团股份有限公司（以下简称"公司"或"中恒集团"）第十 届董事会第三十次会议通知和议案材料于 2025 年 8 月 23 日以电子邮件的方式发 出，会议于 2025 年 8 月 28 日以现场结合通讯方式在广西南宁市江南区高岭路 100 号办公楼会议室召开，公司董事长杨金海先生以通讯方式出席并主持会议。 会议应参加表决董事 7 人，实际参加表决董事 7 人，董事王海润先生、陈虎先生、 独立董事李俊华先生出席现场会议，其他董事以通讯方式参加。会议的召集和召 开符合《公司法》《公司章程》和《公司董事会议事规则》的有关规定。 会议审议并以记名投票方式表决通过以下议案及事项： （一）会议审议通过《广西梧州中恒集团股份有限公司 2025 年半年度报告 （全文及摘要）》； 本报告的具体内容详见公司于 2025 年 8 月 ...

人民财讯8月29日电，中恒集团(600252)8月29日晚间披露半年报，2025年上半年，公司实现营业收入 14.51亿元，同比增长2.84%；归属于上市公司股东的净利润2707.76万元，同比增长23.59%；基本每股 收益0.0082元。 ...

Core Viewpoint - Zhongheng Group (600252) reported a revenue of 1.451 billion yuan for the first half of 2025, reflecting a year-on-year growth of 2.84% [1] - The net profit attributable to shareholders reached 27.08 million yuan, marking a year-on-year increase of 23.59% [1] - Basic earnings per share were reported at 0.0082 yuan [1] Financial Performance - Revenue for the first half of 2025: 1.451 billion yuan, up 2.84% year-on-year [1] - Net profit attributable to shareholders: 27.08 million yuan, up 23.59% year-on-year [1] - Basic earnings per share: 0.0082 yuan [1]

证券代码：600252 证券简称：中恒集团 公告编号：临 2025-77 广西梧州中恒集团股份有限公司 关于受让合伙企业部分合伙份额暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 交易简要内容：广西梧州中恒集团股份有限公司（以下简称"公司"或 "中恒集团"）拟受让广西海晟投资管理有限公司（以下简称"广西海晟"）持有 的广西利穗投资合伙企业（有限合伙）（以下简称"广西利穗"）390 万元合伙份 额（实际投入款项 2,029.95 万元）和广西联合资产管理股份有限公司（以下简称 "联合资管"）持有的广西德富投资合伙企业（有限合伙）（以下简称"广西德 富"）6,600 万元合伙份额，以上合伙份额受让价格合计 10,068 万元。 本次交易中公司与转让方广西海晟、联合资管不存在关联关系。根据相 关规定，广西利穗的有限合伙人广西广投医药健康产业集团有限公司（以下简称 "医健集团"）为公司关联法人，广西德富的有限合伙人广西金控资产管理有限 公司（以下简称"金控资管"）为公司关联法人。因此，公司本次受让广西 ...

广西梧州中恒集团股份有限公司 2025 年半年度报告 公司代码：600252 公司简称：中恒集团 广西梧州中恒集团股份有限公司 2025 年半年度报告 1 / 189 广西梧州中恒集团股份有限公司 2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人杨金海、主管会计工作负责人戈辉及会计机构负责人（会计主管人员）李鹏声明： 保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本半年度报告中所涉及的未来计划、发展战略等前瞻性描述，不构成公司对投资者的实质承 诺，敬请投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 ...

Core Insights - The company reported a revenue of 1.451 billion yuan for the first half of 2025, representing a year-on-year growth of 2.84% [1] - The net profit for the same period was 27.0776 million yuan, showing a significant year-on-year increase of 23.59% [1] Financial Performance - Revenue for the first half of 2025: 1.451 billion yuan, up 2.84% year-on-year [1] - Net profit for the first half of 2025: 27.0776 million yuan, up 23.59% year-on-year [1]

Group 1 - Zhongheng Group (SH 600252) announced on August 27 that the share repurchase program has been completed, with a total repurchase amount exceeding the lower limit of the planned repurchase funds [1] - The company repurchased approximately 118 million shares, accounting for about 3.56% of the total share capital, with a maximum repurchase price of 2.93 yuan per share, a minimum price of 2.3 yuan per share, and an average price of 2.55 yuan per share, using a total of approximately 301 million yuan [1] Group 2 - For the year 2024, Zhongheng Group's revenue composition is as follows: pharmaceutical manufacturing accounts for 76.26%, other businesses account for 13.84%, and food accounts for 9.9% [1]

Key Points - The article highlights significant corporate announcements and performance metrics from various companies in the industry [1][2][3][4] Group 1: Corporate Announcements - Sente Co., Ltd. (森特股份) clarified that it does not engage in "data center" related businesses [1] - Inke Recycling (英科再生) plans to invest approximately $40 million in the construction of the Vietnam Inke Qinghua (Phase III) project [1] - Daikin Heavy Industries (大金重工) signed its first overseas contract for the construction of a heavy deck transport vessel [1] - Zancaiya (咱菜雅) is planning to issue H-shares [1] - Biyimi (必易微) intends to acquire 100% equity of Xingan Semiconductor for 295 million yuan [1] - Zhongheng Group (中恒集团) has repurchased 3.5649% of its shares [1] - Nanjing New Pharmaceutical (南新制药) signed a letter of intent for acquisition with Future Pharmaceutical [3] - Pan-Asia Microelectronics (泛亚微透) plans to raise no more than 699 million yuan through a private placement [1][4] Group 2: Financial Performance - Shenghong Technology (胜宏科技) reported a net profit of 2.143 billion yuan for the first half of the year, a year-on-year increase of 366.89% [2] - Zhongji Xuchuang (中际旭创) saw a year-on-year net profit increase of 69.4% and plans to distribute 4 yuan per 10 shares [2] - Cambrian (寒武纪) achieved a net profit of 1.038 billion yuan in the first half of the year, marking a turnaround from losses [2] - China National Petroleum Corporation (中国石油) reported a net profit of 84.01 billion yuan for the first half of the year [2] Group 3: Shareholding Changes - Several companies, including Xindong Lian Ke (芯动联科) and Shenkeda (深科达), announced plans for share reductions by major shareholders [4] - Chaoyang Technology (朝阳科技) and Zhongwei Company (中微公司) also plan to reduce their shareholdings by up to 3% and 2%, respectively [4]

Group 1 - The core point of the article is that Zhongheng Group has completed its share repurchase program, with a total repurchase amount exceeding the lower limit of the planned repurchase funds [1] - As of August 25, 2025, the company has repurchased a total of 118,117,197 shares, which represents 3.5649% of the company's total share capital [1]

Core Viewpoint - Zhongheng Group (600252.SH) has completed its share repurchase program, exceeding the lower limit of the total repurchase funds outlined in the plan [1] Summary by Relevant Sections - **Share Repurchase Details** - The company repurchased a total of 118 million shares, accounting for 3.5649% of the total share capital [1] - The highest repurchase price was 2.93 CNY per share, while the lowest was 2.30 CNY per share, with an average repurchase price of 2.55 CNY per share [1] - The total amount of funds used for the repurchase was 300 million CNY, excluding transaction fees such as stamp duty and commissions [1]